Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation
1 clinical trials · Condition
◉ Watch Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma (NCT07712757) | Nuvation Bio Inc. | 2027-03-01 |
Track Grade 2 Glioma (Astrocytoma or Oligodendroglioma) With an IDH1 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.